Allergan Golden Parachute

Allergan CEO Davis Pyott may have a very soft landing if the Activas acquisition of Allergan is completed. Actavis announced that after the merger was complete, it planned to replace most of Allergan's executives. In Pyott's case, if he were fired after the merger, he would receive $89 million in cash and stock for equity rewards that have yet to vest, $9.91 million in cash, and $2 million in accrued pension and health benefits, for a total payout of over $100 million!